Tegoprazan Impurity 34 | CAS 2892269-71-3 - Request Quote
Tegoprazan Impurity 34
| SZ CAT No: | SZ-T098043 |
| CAS No | 2892269-71-3 |
| Mol.F. | C18H18BrN3O |
| Mol.Wt. | 372.3 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tegoprazan Impurity 34 is chemically 1-Benzyl-7-bromo-N,N,2-trimethyl-1H-benzo[d]imidazole-5-carboxamide. Tegoprazan Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Tegoprazan Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tegoprazan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2892269-71-3
Purchase 2892269-71-3
Order 2892269-71-3
Enquire 2892269-71-3
price of 2892269-71-3
2892269-71-3 Supplier
2892269-71-3 Manufacturer
2892269-71-3 Exporter
buy high quality Tegoprazan Impurity 34
Purchase Tegoprazan Impurity 34
Tegoprazan Impurity 34 suppliers
Tegoprazan Impurity 34 manufacturers
Tegoprazan Impurity 34 price
Order Tegoprazan Impurity 34
Enquire Tegoprazan Impurity 34
Tegoprazan Impurity 34 cost
Tegoprazan Impurity 34 Supplier
Tegoprazan Impurity 34 Distributor
Tegoprazan Impurity 34 for Method Validation
Tegoprazan Reference Standard
Tegoprazan Impurity 34 for ANDA Filing
Tegoprazan Impurity 34 for Forced Degradation Studies
Tegoprazan Impurity 34 Identification Standards
Tegoprazan Impurity 34 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.